New pill takes on tough breast cancer in first human trial
NCT ID NCT07581314
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a new oral drug called Zn-Telomir in people with advanced or metastatic triple-negative breast cancer (TNBC) who have already tried other treatments. The trial has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. About 76 adults will take part. The goal is to control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER (TNBC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.